Vistin Pharma ASA (OSL:VISTN)
Norway · Delayed Price · Currency is NOK 23.80
-0.10 (-0.42%)
At close: Aug 22, 2025
Vistin Pharma ASA Market Cap
Vistin Pharma ASA has a market cap or net worth of 1.06 billion as of August 25, 2025. Its market cap has increased by 9.63% in one year.
Market Cap
1.06B
Enterprise Value
1.15B
Revenue
452.25M
Ranking
n/a
PE Ratio
13.93
Stock Price
23.80
Market Cap Chart
Since June 10, 2015, Vistin Pharma ASA's market cap has increased from 322.34M to 1.06B, an increase of 228.80%. That is a compound annual growth rate of 12.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 22, 2025 | 1.06B | 0.42% |
| Dec 30, 2024 | 1.05B | 1.72% |
| Dec 29, 2023 | 1.03B | 47.47% |
| Dec 30, 2022 | 700.64M | -18.47% |
| Dec 30, 2021 | 859.40M | 11.06% |
| Dec 30, 2020 | 773.81M | 67.79% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medistim ASA | 4.80B |
| Nordhealth AS | 2.90B |
| Photocure ASA | 1.65B |
| ArcticZymes Technologies ASA | 1.50B |
| Omda AS | 1.02B |
| Thor Medical ASA | 960.12M |
| Gentian Diagnostics ASA | 879.07M |
| Lytix Biopharma AS | 638.93M |